(+)-Byakangelicin

Details

Top
Internal ID 944cdb2e-f229-439a-ab71-5c52e0dade80
Taxonomy Phenylpropanoids and polyketides > Coumarins and derivatives > Furanocoumarins > Psoralens > 5-methoxypsoralens
IUPAC Name 9-[(2R)-2,3-dihydroxy-3-methylbutoxy]-4-methoxyfuro[3,2-g]chromen-7-one
SMILES (Canonical)
SMILES (Isomeric)
InChI InChI=1S/C17H18O7/c1-17(2,20)11(18)8-23-16-14-10(6-7-22-14)13(21-3)9-4-5-12(19)24-15(9)16/h4-7,11,18,20H,8H2,1-3H3/t11-/m1/s1
InChI Key PKRPFNXROFUNDE-LLVKDONJSA-N
Popularity 47 references in papers

Physical and Chemical Properties

Top
Molecular Formula C17H18O7
Molecular Weight 334.30 g/mol
Exact Mass 334.10525291 g/mol
Topological Polar Surface Area (TPSA) 98.40 Ų
XlogP 1.60
Atomic LogP (AlogP) 2.06
H-Bond Acceptor 7
H-Bond Donor 2
Rotatable Bonds 5

Synonyms

Top
482-25-7
Biacangelicin
Bjacangelicin
Bjakangelicin
Byankagelicine
(+)-Byakangelicin
7H-Furo(3,2-g)(1)benzopyran-7-one, 9-(2,3-dihydroxy-3-methylbutoxy)-4-methoxy-, (R)-
LE80Z850I1
DTXSID70197456
9-[(2R)-2,3-dihydroxy-3-methylbutoxy]-4-methoxyfuro[3,2-g]chromen-7-one
There are more than 10 synonyms. If you wish to see them all click here.

2D Structure

Top
2D Structure of (+)-Byakangelicin

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.9610 96.10%
Caco-2 - 0.6261 62.61%
Blood Brain Barrier - 0.7250 72.50%
Human oral bioavailability + 0.5286 52.86%
Subcellular localzation Mitochondria 0.7552 75.52%
OATP2B1 inhibitior - 1.0000 100.00%
OATP1B1 inhibitior + 0.9306 93.06%
OATP1B3 inhibitior + 0.8331 83.31%
MATE1 inhibitior - 0.8800 88.00%
OCT2 inhibitior - 0.9000 90.00%
BSEP inhibitior - 0.5211 52.11%
P-glycoprotein inhibitior - 0.6847 68.47%
P-glycoprotein substrate - 0.7416 74.16%
CYP3A4 substrate + 0.5175 51.75%
CYP2C9 substrate - 0.6661 66.61%
CYP2D6 substrate - 0.8264 82.64%
CYP3A4 inhibition - 0.9321 93.21%
CYP2C9 inhibition - 0.9168 91.68%
CYP2C19 inhibition - 0.8579 85.79%
CYP2D6 inhibition - 0.8449 84.49%
CYP1A2 inhibition - 0.7040 70.40%
CYP2C8 inhibition - 0.6156 61.56%
CYP inhibitory promiscuity - 0.9135 91.35%
UGT catelyzed + 0.8000 80.00%
Carcinogenicity (binary) - 1.0000 100.00%
Carcinogenicity (trinary) Non-required 0.5403 54.03%
Eye corrosion - 0.9888 98.88%
Eye irritation - 0.7784 77.84%
Skin irritation - 0.8049 80.49%
Skin corrosion - 0.9537 95.37%
Ames mutagenesis - 0.7600 76.00%
Human Ether-a-go-go-Related Gene inhibition - 0.4066 40.66%
Micronuclear - 0.5067 50.67%
Hepatotoxicity + 0.7375 73.75%
skin sensitisation - 0.8170 81.70%
Respiratory toxicity + 0.6111 61.11%
Reproductive toxicity + 0.8222 82.22%
Mitochondrial toxicity + 0.6625 66.25%
Nephrotoxicity - 0.8882 88.82%
Acute Oral Toxicity (c) III 0.6931 69.31%
Estrogen receptor binding + 0.8014 80.14%
Androgen receptor binding + 0.6710 67.10%
Thyroid receptor binding + 0.5840 58.40%
Glucocorticoid receptor binding + 0.7474 74.74%
Aromatase binding + 0.6453 64.53%
PPAR gamma + 0.8260 82.60%
Honey bee toxicity - 0.8732 87.32%
Biodegradation - 0.7500 75.00%
Crustacea aquatic toxicity - 0.6900 69.00%
Fish aquatic toxicity + 0.8597 85.97%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
CHEMBL4822 P56817 Beta-secretase 1 219700 nM
IC50
PMID: 22222157
CHEMBL1293226 B2RXH2 Lysine-specific demethylase 4D-like 39810.7 nM
Potency
via CMAUP

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL2581 P07339 Cathepsin D 97.25% 98.95%
CHEMBL4040 P28482 MAP kinase ERK2 97.20% 83.82%
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 96.46% 91.11%
CHEMBL4261 Q16665 Hypoxia-inducible factor 1 alpha 96.23% 85.14%
CHEMBL2635 P51452 Dual specificity protein phosphatase 3 90.83% 94.00%
CHEMBL4203 Q9HAZ1 Dual specificity protein kinase CLK4 89.28% 94.45%
CHEMBL3401 O75469 Pregnane X receptor 88.35% 94.73%
CHEMBL3060 Q9Y345 Glycine transporter 2 88.19% 99.17%
CHEMBL3108638 O15164 Transcription intermediary factor 1-alpha 87.82% 95.56%
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 85.55% 96.09%
CHEMBL2535 P11166 Glucose transporter 84.51% 98.75%
CHEMBL1806 P11388 DNA topoisomerase II alpha 83.70% 89.00%
CHEMBL253 P34972 Cannabinoid CB2 receptor 83.13% 97.25%
CHEMBL3038477 P67870 Casein kinase II alpha/beta 81.49% 99.23%
CHEMBL4306 P22460 Voltage-gated potassium channel subunit Kv1.5 81.42% 94.03%

Cross-Links

Top
PubChem 10211
NPASS NPC224165
ChEMBL CHEMBL508648
LOTUS LTS0166000
wikiData Q3639306